|
|
|
|
| LEADER |
01967nmm a2200313 u 4500 |
| 001 |
EB000633220 |
| 003 |
EBX01000000000000000486302 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9781489912626
|
| 100 |
1 |
|
|a Shah, Vinod P.
|e [editor]
|
| 245 |
0 |
0 |
|a Topical Drug Bioavailability, Bioequivalence, and Penetration
|h Elektronische Ressource
|c edited by Vinod P. Shah, Howard I. Maibach
|
| 250 |
|
|
|a 1st ed. 1993
|
| 260 |
|
|
|a New York, NY
|b Springer US
|c 1993, 1993
|
| 300 |
|
|
|a XXII, 453 p
|b online resource
|
| 505 |
0 |
|
|a A Medical Rationale -- 3 Prodrugs and Their Topical Use -- 4 Ultrasound-Mediated Transdermal Drug Delivery -- II In Vitro Methodology -- 5 Practical Considerations in Developing a Quality Control (In Vitro Release) Procedure for Topical Drug Products -- 6 Diffusion Cell Design -- III In Vivo Methodology -- 7 Cutaneous Bioavailability, Bioequivalence, and Percutaneous Absorption: In Vivo Methods, Problems, and Pitfalls -- 8 The Human Skin Blanching Assay for Topical Corticosteroid Bioavailability Assessment -- 9 Predictive Approaches I: The Stripping Technique -- 10 Predictive Approaches II: Mass-Balance Procedure -- 11 In Vivo Topical Bioavailability and Skin Decontamination: Example Alachlor -- 12 Grafted Skin and Skin Flaps -- IV Factors Influencing Percutaneous Transport -- 13 In Vivo and In Vitro Skin Uptake and Permeation Studies: Critical Considerations and Factors Which Affect Them -- 14 V
|
| 653 |
|
|
|a Animal physiology
|
| 653 |
|
|
|a Biological physics
|
| 653 |
|
|
|a Animal Physiology
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Biophysics
|
| 653 |
|
|
|a Biological and Medical Physics, Biophysics
|
| 653 |
|
|
|a Pharmacology/Toxicology
|
| 700 |
1 |
|
|a Maibach, Howard I.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4899-1262-6?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615
|